Our results indicated the presence of elevated levels of anti‐SARS‐CoV‐2‐specific IgE in COVID‐19 patients and that the levels of these antibodies were higher in severe disease patients than in non‐severe disease patients. The gene discussed is IGHE; the disease is COVID-19.